Search results for "PAM"

showing 10 items of 1768 documents

Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue

2021

Acromegaly is a disease mainly caused by pituitary neuroendocrine tumor (PitNET) overproducing growth hormone. First-line medication for this condition is the use of somatostatin analogs (SSAs), that decrease tumor mass and induce antiproliferative effects on PitNET cells. Dopamine agonists (DAs) can also be used if SSA treatment is not effective. This study aimed to determine differences in transcriptome signatures induced by SSA/DA therapy in PitNET tissue. We selected tumor tissue from twelve patients with somatotropinomas, with half of the patients receiving SSA/DA treatment before surgery and the other half treatment naive. Transcriptome sequencing was then carried out to identify diff…

Cancer Researchbusiness.industrysomatostatin/dopamine (SSA/DA) therapynext generation sequencing (NGS)medicine.disease_causemedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282TranscriptomeExtracellular matrixSomatostatinOncologyDownregulation and upregulationDopamineGene expressionAcromegalyCancer researchMedicineacromegalysomatotropinomabusinessCarcinogenesistranscriptomeOriginal Researchmedicine.drugFrontiers in Oncology
researchProduct

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

2006

Contains fulltext : 35205.pdf (Publisher’s version ) (Closed access) Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, starting in early childhood and persisting into adulthood in the majority of cases. Family and twin studies have demonstrated the importance of genetic factors and candidate gene association studies have identified several loci that exert small but significant effects on ADHD. To provide further clarification of reported associations and identify novel associated genes, we examined 1,038 single-nucleotide polymorphisms (SNPs) spanning 51 candidate genes involved in the regulation of neurotransmitter pathways, particularly dopamine, nor…

Candidate geneGenetics and epigenetic pathways of disease [NCMLS 6]MedizinReceptors NicotinicTryptophan HydroxylaseNeuroinformatics [DCN 3]0302 clinical medicinePerception and Action [DCN 1]Determinants in Health and Disease [EBP 1]ChildOncogene ProteinsGenetics0303 health sciencesbiologyDNA POOLING ANALYSISPedigree3. Good healthserotoninPsychiatry and Mental healthConduct disorderChild Preschool/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingMonoamine oxidase AdopaminePsychologyFunctional Neurogenomics [DCN 2]Genetic MarkersAdolescentSynaptosomal-Associated Protein 25Single-nucleotide polymorphismassociation studyPolymorphism Single NucleotideMental health [NCEBP 9]Genetic determinismGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesCellular and Molecular NeuroscienceMONOAMINE-OXIDASE-ACognitive neurosciences [UMCN 3.2]SDG 3 - Good Health and Well-beingmental disordersmedicineHumansAttention deficit hyperactivity disorderADHDGenetic Predisposition to Disease5-HT1B RECEPTOR GENEddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersMonoamine OxidaseMolecular Biology030304 developmental biologyGenetic associationDopamine Plasma Membrane Transport ProteinsSEROTONIN TRANSPORTER GENEDOPAMINE-BETA-HYDROXYLASESiblingsReceptors Dopamine D4candidate genemedicine.diseaseTwin studyPREFERENTIAL TRANSMISSIONHaplotypesCATECHOL-O-METHYLTRANSFERASEAttention Deficit Disorder with HyperactivityCONDUCT DISORDERbiology.proteinnoradrenalineDEFICIT/HYPERACTIVITY DISORDERNO EVIDENCE030217 neurology & neurosurgerylinkage disequilibriumMolecular Psychiatry
researchProduct

The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB(1)).

2012

Endocannabinoids exert numerous effects in the CNS under physiological and pathological conditions. The aim of the present study was to examine whether the endocannabinoid N-arachidonoyldopamine (NADA) may protect neurons in excitotoxically lesioned organotypic hippocampal slice cultures (OHSC). OHSC were excitotoxically lesioned by application of N-methyl-d-aspartate (NMDA, 50 μM) for 4 h and subsequently treated with different NADA concentrations (0.1 pM-50 μM) alone or in combination with cannabinoid receptor antagonists. NADA protected dentate gyrus granule cells and caused a slight reduction in the number of microglial cells. The number of degenerated neurons significantly decreased be…

Cannabinoid receptorDopamineTRPV1Arachidonic AcidsPharmacologyNeuroprotectionHippocampusCellular and Molecular NeuroscienceMicePiperidinesReceptor Cannabinoid CB1Neuronal damageAnimalsRats WistarCells CulturedPharmacologyNeuronsChemistryDentate gyrusExcitatory Postsynaptic PotentialsEndocannabinoid systemRatsNeuroprotective Agentsnervous systemNerve DegenerationCannabinoid receptor antagonistNMDA receptorPyrazolesNeuropharmacology
researchProduct

Circuit Specific Functions of Cannabinoid CB1 Receptor in the Balance of Investigatory Drive and Exploration

2011

Well balanced novelty seeking and exploration are fundamental behaviours for survival and are found to be dysfunctional in several psychiatric disorders. Recent studies suggest that the endocannabinoid (eCB) system is an important control system for investigatory drive. Pharmacological treatment of rodents with cannabinergic drugs results in altered social and object investigation. Interestingly, contradictory results have been obtained, depending on the treatment, drug concentration and experimental conditions. The cannabinoid type 1 (CB1) receptor, a central component of the eCB system, is predominantly found at the synapses of two opposing neuronal populations, i.e. on inhibitory GABAerg…

Cannabinoid receptorMousemedicine.medical_treatmentScienceGlutamic AcidNeural HomeostasisMice TransgenicBiologyMedium spiny neuronSynaptic Transmissiongamma-Aminobutyric acidGlutamatergicBehavioral NeuroscienceMiceModel OrganismsReceptor Cannabinoid CB1medicineGeneticsAnimalsGABAergic NeuronsSocial BehaviorBiologygamma-Aminobutyric AcidPsychiatryNeuronsMultidisciplinaryBehavior AnimalMood DisordersQRAnimal ModelsNeurotransmittersEndocannabinoid systemMice Inbred C57BLMental Healthnervous systemDopamine receptorMaladjustmentExploratory BehaviorGABAergicMedicineCannabinoidNeuroscienceAnimal Geneticsmedicine.drugResearch ArticleNeurosciencePLoS ONE
researchProduct

Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats

2013

Increasing evidence focuses on acetaldehyde (ACD) as the mediator of the rewarding and motivational properties of ethanol. Indeed, ACD stimulates dopamine release in the nucleus accumbens and it is self-administered under different conditions. Besides the dopaminergic transmission, the endocannabinoid system has been reported to play an important role in ethanol central effects, modulating primary alcohol rewarding effect, drug-seeking and relapse behaviour. Drug motivational properties are highlighted in operant paradigms which include response-contingent punishment, a behavioural equivalent of compulsive drug use despite adverse consequences. The aim of this study was thus to characterize…

Cannabinoid receptorPunishment (psychology)media_common.quotation_subjectCognitive NeuroscienceNucleus accumbenslcsh:RC321-571Behavioral NeuroscienceDopamineCB1 AntagonistmedicineOriginal Research ArticleGeiller-Seifter procedurelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrymedia_commonrelapseAddictionDopaminergicExtinction (psychology)Endocannabinoid systemGeiller–Seifter procedureNeuropsychology and Physiological PsychologyCB1 receptor blockade/antagonismSettore BIO/14 - FarmacologiaAcetaldehyde Lever pressing relapse Geiller-Seifter procedure CB1 receptor blockade/antagonismPsychologyNeurosciencepsychological phenomena and processesmedicine.drugNeuroscienceacetaldehydelever pressingFrontiers in Behavioral Neuroscience
researchProduct

Cambio Climático. Objetivo Durbán

2011

Revista Eureka sobre Enseñanza y Divulgación de las Ciencias está contribuyendo, con la publicación de numerosos trabajos y, en particular, con su sección "Educación científica y sostenibilidad", a los objetivos de la Década de la educación por un futuro sostenible, instituida por Naciones Unidas para que los educadores de todos los niveles y áreas contribuyamos a proporcionar una percepción correcta de los problemas a los que se enfrente la humanidad y a fomentar actitudes y comportamientos favorables para el logro de un futuro sustentable. Acogiéndonos a este compromiso de Revista Eureka queremos hacernos eco de los resultados de la Cumbre del Clima celebrada en Cancún en diciembre de 201…

Canvi mediambiental globalDesenvolupament sostenibleEducació ambiental
researchProduct

El cambio climático, ¿una cuestión de fanatismo ecológico?

2008

Climatic change has given place to pseudo-scientific debates that demand clarification in order to make possible citizens responsible attitudes and behavior oriented towards the attainment of a culturally plural and physically sustainable development.

Canvi mediambiental globalDesenvolupament sostenibleMedi ambient ProteccióEcologia
researchProduct

De Cancún a Durbán: la necesidad de un activismo basado en el conocimiento

2010

El Caderno Brasileiro de Ensino de Física ha hecho suyo los llamamientos de Naciones Unidas - que han culminado con la institución de la Década de la educación por un futuro sostenible - para que los educadores de todos los niveles y áreas prestemos una atención sistemática a la situación del mundo y contribuyamos a proporcionar una percepción correcta de los problemas a los que se enfrente la humanidad y a fomentar actitudes y comportamientos favorables para el logro de un futuro sustentable. Llamamientos convergentes se han realizado a los miembros de la comunidad científica. Podemos recordar, a título de ejemplo, el artículo editorial publicado en 1998 por Jane Lubchenco, presidenta a la…

Canvi mediambiental globalEducació ambientalDesenvolupament sostenibleCiència Ensenyament
researchProduct

Caisses de sécurité sociale : ne notifiez plus vos décisions !

2019

International audience

Caractère professionnel de l'accident[SHS.DROIT]Humanities and Social Sciences/LawAccident du Travail[SHS.DROIT] Humanities and Social Sciences/LawRefusProcédureDécision de la CPAMComputingMilieux_MISCELLANEOUS
researchProduct

Integrated non-invasive approach to atherosclerosis with cardiac CT and carotid ultrasound in patients with suspected coronary artery disease

2017

The aim of the study was to compare the atherosclerotic disease in the coronary and carotid arteries in patients who underwent non-invasive imaging for suspected stable coronary artery disease (CAD). 107 patients (64 men, age 59 ± 12) with atypical chest pain underwent cardiac CT (CCT) and carotid ultrasound (US) on the same day. Severity (obstructive or not-obstructive disease), location, shape, and composition of atherosclerotic plaques in the two districts were evaluated. Patients presented normal coronary arteries in 36 % (n = 38), not-obstructive CAD in 36 % (n = 39), and obstructive CAD in 28 % (n = 30), while had normal carotid arteries in 53 % (n = 57), not-obstructive disease in 44…

Carotid ultrasoundMalemedicine.medical_specialtyCarotid arteriesCardiac-Gated Imaging TechniquesContrast Media030204 cardiovascular system & hematologyCoronary AngiographySeverity of Illness IndexCoronary artery diseaseDoppler ultrasound030218 nuclear medicine & medical imagingLesionCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineImage Interpretation Computer-AssistedmedicineCardiac CTHumansRadiology Nuclear Medicine and imagingIn patientCarotid StenosisNeuroradiologyUltrasonographymedicine.diagnostic_testbusiness.industryUltrasoundInterventional radiologyCarotid arterieGeneral MedicineMiddle Agedmedicine.diseaseAtherosclerosisIopamidolAtherosclerosiCardiologyFemaleRadiologymedicine.symptombusinessTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiaRadiologia Medica
researchProduct